Journals
Publish with us
Publishing partnerships
About us
Blog
Mediators of Inflammation
+
Journal Menu
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Submit
Mediators of Inflammation
/
Table of Contents: 1995
Table of Contents
1995
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
Table of Contents: 1995
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 709586
Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine
R. Gerth van Wijk
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 654634
A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management
Peter H. Howarth
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 148986
Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts
Marianela de Azevedo
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 795712
Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children
Brunello Wüthrich | Martin Gerber
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 582151
Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis
Ralph Mösges | Joachim Spaeth | Ludger Klimek
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 924194
Faster onset of action with topical levocabastine than with oral cetirizine
Michel A. Drouin | William H. Yang | Frederick Horak
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
- Volume 4
- Article ID 207175
Introduction
Paul Van Cauwenberge
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 828473
Calendar
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 528646
Book review
Johan C. de Jongste
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 408269
Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms
S. Sipka | T. Seres | ... | G. Szegedi
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 878946
Clostridium difficile
suppresses colonic vasoactive intestinal peptide associated with altered motility
A. Nassif | W. E. Longo | ... | D. L. Kaminski
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 718741
Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNF
α
A. Molina | F. Sánchez-Madrid | ... | F. Mampaso
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 973735
Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime
M. Mathy-Hartert | G. Deby-Dupont | ... | M. Lamy
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 592569
Nitric oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats
M. R. Pierce | C. A. Voelker | ... | M. J. S. Miller
N/A
PDF
Download PDF
Citation
Download citation
Mediators of Inflammation
-
Special Issue
Volume 4
- Article ID 357234
Lower leukotriene C
4
levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy
Y. Oosterhoff | S. E. Overbeek | ... | F. J. Zijlstra
N/A
PDF
Download PDF
Citation
Download citation
First
1
|
2
|
3
|
4
|
5
|
6
Last
First
1
|
2
|
3
|
4
Last
Journal metrics
Acceptance rate
36%
Submission to final decision
53 days
Acceptance to publication
29 days
CiteScore
6.000
Impact Factor
3.758
Submit
Author guidelines
Editorial board
Databases and indexing
Sign up for content alerts
Sign up